Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This randomized clinical trial aims to compare the effect of the pioglitazone and SGLT2 inhibitor combination on liver fat mass, as compared to either drug used alone, with or without background medical therapy of metformin and/or DDP4 inhibitors.
Epistemonikos ID: 1e06e643e9ab140f229ea750f3fe707b70760693
First added on: May 09, 2024